V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160015526 | 160013002 | 1.65 | 73 | null | 2018-01-27 | 2018-03-02 | Doxorubicin + Olaratumab | 02 | null | DOXORUBICIN + OLARATUMAB | 100474742 |
| 160015528 | 160013003 | 1.53 | 117.4 | Neo-adjuvant (N) | 2016-05-21 | 2016-06-03 | CARBOPLATIN + PACLITAXEL | 02 | null | CARBOPLATIN + PACLITAXEL | 101653921 |
| 160015532 | 160013004 | 1.71 | 66.15 | Palliative (P) | 2017-01-02 | 2017-01-02 | Liposomal Doxorubicin 50mg/m2 | 02 | N | LIPOSOMAL DOXORUBICIN | 101807246 |
| 160015533 | 160013005 | 1.71 | 48 | Disease modification (D) | 2019-07-27 | 2019-08-02 | Liposomal Doxorubicin 50mg/m2 | 01 | N | LIPOSOMAL DOXORUBICIN | 101814440 |
| 160015535 | 160013006 | 1.84 | null | null | 2018-01-08 | 2018-01-29 | Bevacizumab | 02 | null | DOCETAXEL + GEMCITABINE | 101424685 |
| 160015536 | 160013007 | 1.72 | 65 | null | null | 2021-07-30 | Bevacizumab | 02 | null | PACLITAXEL | 101364893 |
| 160015541 | 160013008 | 1.72 | 45 | Palliative (P) | 2018-01-10 | 2018-01-20 | Bevacizumab 7.5mg/kg | 02 | N | DOCETAXEL + GEMCITABINE | 100909480 |
| 160015545 | 160013009 | 1.54 | 47.3 | Neo-adjuvant (N) | 2016-10-13 | 2016-12-08 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101403798 |
| 160015547 | 160013010 | 1.53 | 77.2 | Palliative (P) | 2018-09-18 | 2018-09-18 | Bevacizumab | 02 | N | CARBOPLATIN + PACLITAXEL | 101260596 |
| 160015548 | 160013011 | 1.5 | 71.55 | Neo-adjuvant (N) | 2020-05-12 | 2020-06-03 | Bevacizumab 7.5mg/kg | 02 | N | DOCETAXEL + GEMCITABINE | 101738382 |
| 160015553 | 160013012 | 1.67 | 73.2 | null | 2022-03-02 | 2022-03-20 | CARBOPLATIN + PACLITAXEL | null | null | CARBOPLATIN + PACLITAXEL | 101523844 |
| 160015559 | 160013013 | 1.53 | 73.5 | null | 2020-06-29 | 2021-03-28 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100215341 |
| 160015562 | 160013014 | 1.73 | 71.5 | Neo-adjuvant (N) | 2017-06-07 | 2017-06-28 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN | 100083636 |
| 160015563 | 160013015 | 1.69 | 65 | 03 | 2022-03-02 | 2022-03-16 | Bevacizumab 7.5mg/kg | 02 | N | BEVACIZUMAB | 100221532 |
| 160015564 | 160013016 | 1.43 | 88.2 | null | 2017-01-21 | 2017-02-18 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 100226517 |
| 160015567 | 160013017 | 1.82 | 70 | Palliative (P) | 2018-12-04 | 2018-12-04 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 101165601 |
| 160015570 | 160013018 | 1.71 | 0 | Palliative (P) | 2016-04-13 | 2017-10-23 | Bevacizumab | null | null | PACLITAXEL | 100897573 |
| 160015572 | 160013019 | 1.84 | 81 | Neo-adjuvant (N) | 2018-09-27 | 2018-10-04 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101189221 |
| 160015590 | 160013020 | 1.85 | 67.9 | Palliative (P) | 2018-10-27 | 2018-11-22 | Liposomal Doxorubicin 40mg/m2 | 02 | N | LIPOSOMAL DOXORUBICIN | 101389930 |
| 160015591 | 160013021 | 1.6 | 38 | Palliative (P) | 2017-07-26 | 2017-08-09 | Bevacizumab 7.5mg/kg | 01 | N | CARBOPLATIN | 100232763 |
| 160015593 | 160013022 | 1.5 | 68 | Palliative (P) | 2019-01-27 | 2019-02-08 | Carboplatin AUC 2 - 5 | 02 | N | DOXORUBICIN + OLARATUMAB | 100812647 |
| 160015595 | 160013023 | 1.71 | 44.65 | Palliative (P) | null | 2018-03-22 | Bevacizumab | 02 | N | PACLITAXEL | 100668641 |
| 160015597 | 160013024 | 1.67 | 96.7 | Palliative (P) | 2018-11-16 | 2018-11-16 | GEMCARBO | 2 | N | CARBOPLATIN + GEMCITABINE | 101417937 |
| 160015598 | 160013025 | 1.44 | 88.15 | Adjuvant (A) | 2021-04-27 | 2021-05-04 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 100842077 |
| 160015600 | 160013026 | 1.54 | 63.2 | null | 2021-03-31 | 2021-05-17 | Doxorubicin + Olaratumab | 02 | null | DOXORUBICIN + OLARATUMAB | 101463599 |
| 160015601 | 160013027 | 1.78 | 70 | Palliative (P) | 2018-03-26 | 2018-03-27 | Bevacizumab 15mg/kg | N | N | CARBOPLATIN | 100749332 |
| 160015610 | 160013028 | 1.82 | 67.2 | Palliative (P) | 2016-03-11 | 2016-04-28 | Bevacizumab 7.5mg/kg | 02 | N | PACLITAXEL | 101394880 |
| 160015611 | 160013029 | 1.54 | 60.8 | 03 | 2017-03-29 | 2017-06-23 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + PACLITAXEL | 101580672 |
| 160015614 | 160013030 | 1.77 | 90.1 | null | 2017-01-27 | 2017-02-02 | LIPOSOMAL DOXORUBICIN | 02 | null | LIPOSOMAL DOXORUBICIN | 100093550 |
| 160015618 | 160013031 | 1.68 | 68.9 | Palliative (P) | 2020-05-20 | 2020-06-29 | Bevacizumab 7.5mg/kg | 02 | N | DOCETAXEL + GEMCITABINE | 101108126 |
| 160015619 | 160013032 | 1.85 | 58.7 | Palliative (P) | 2017-12-28 | 2018-04-06 | Bevacizumab 7.5mg/kg | 02 | null | PACLITAXEL | 101077632 |
| 160015623 | 160013033 | 1.51 | 70 | Palliative (P) | 2018-11-12 | 2018-11-12 | Bevacizumab | 02 | N | BEVACIZUMAB | 101534230 |
| 160015626 | 160013034 | 1.7 | 59.55 | Palliative (P) | 2019-03-05 | 2019-03-05 | Bevacizumab 7.5mg/kg | 02 | N | DOXORUBICIN + OLARATUMAB | 100794700 |
| 160015628 | 160013035 | 1.68 | 68.6 | null | null | 2018-03-26 | Bevacizumab 7.5mg/kg | 02 | null | CARBOPLATIN + PACLITAXEL | 101653004 |
| 160015631 | 160013036 | 1.79 | 49.2 | Palliative (P) | 2017-12-05 | 2017-12-09 | PACLITAXEL | 2 | N | PACLITAXEL | 100973029 |
| 160015641 | 160013037 | 1.63 | 66.5 | null | 2017-01-07 | 2017-01-07 | Bevacizumab 7.5mg/kg | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100324209 |
| 160015642 | 160013038 | null | 62 | Palliative (P) | 2017-09-13 | 2017-10-15 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + PACLITAXEL | 100560198 |
| 160015643 | 160013039 | 1.44 | 66.5 | null | 2018-12-20 | 2019-04-28 | Docetaxel + Gemcitabine with GCSF | 02 | null | DOCETAXEL + GEMCITABINE | 100398069 |
| 160015645 | 160013040 | 1.63 | 74.7 | null | 2019-07-13 | 2019-07-16 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 101040941 |
| 160015646 | 160013041 | 1.74 | 73.6 | Palliative (P) | 2017-12-06 | 2018-08-08 | PACLITAXEL | 02 | N | PACLITAXEL | 100571836 |
| 160015647 | 160013042 | 1.76 | 70 | Disease modification (D) | 2017-04-17 | 2017-05-17 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 100852246 |
| 160015651 | 160013043 | 1.76 | 66 | Adjuvant (A) | 2018-12-21 | 2019-05-04 | Bevacizumab | 02 | N | DOXORUBICIN + OLARATUMAB | 101700481 |
| 160015659 | 160013044 | 1.8 | 89 | Palliative (P) | 2018-02-25 | 2018-03-18 | CARBOPLATIN + PACLITAXEL | N | N | CARBOPLATIN + PACLITAXEL | 101513351 |
| 160015661 | 160013045 | 1.83 | 50.5 | Palliative (P) | 2019-04-01 | 2019-04-01 | Liposomal Doxorubicin (Caelyx) | 02 | N | LIPOSOMAL DOXORUBICIN | 101159988 |
| 160015663 | 160013046 | 1.71 | 114 | Palliative (P) | 2017-08-15 | 2017-08-21 | DOCETAXEL + GEMCITABINE | 02 | N | DOCETAXEL + GEMCITABINE | 100567330 |
| 160015669 | 160013047 | 1.72 | 141 | null | 2017-01-31 | 2017-02-14 | Bevacizumab 7.5mg/kg | 02 | null | PACLITAXEL | 101035218 |
| 160015677 | 160013048 | 1.49 | 96.7 | Palliative (P) | 2019-04-23 | 2019-05-14 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100005753 |
| 160015678 | 160013049 | 1.64 | 57.7 | 03 | 2017-03-30 | 2017-04-24 | CYCLOPHOSPHAMIDE | 02 | N | ETOPOSIDE + RITUXIMAB | 100269210 |
| 160015679 | 160013050 | 1.68 | 31 | Curative (C) | 2017-06-06 | 2017-06-07 | Trastuzumab 21 day maintenance | 02 | N | CYCLOPHOSPHAMIDE | 100494943 |
| 160015680 | 160013051 | 0 | 74.9 | null | 2018-12-02 | 2018-12-02 | VIM Trial | 02 | null | PEMBROLIZUMAB | 100092291 |